Global Artificial Heart and Ventricular Assist Devices Market Growth 2023-2029

Global Artificial Heart and Ventricular Assist Devices Market Growth 2023-2029

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) — also known as a mechanical circulatory support device — is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.

LPI (LP Information)' newest research report, the “Artificial Heart and Ventricular Assist Devices Industry Forecast” looks at past sales and reviews total world Artificial Heart and Ventricular Assist Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Heart and Ventricular Assist Devices sales for 2023 through 2029. With Artificial Heart and Ventricular Assist Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Heart and Ventricular Assist Devices industry.

This Insight Report provides a comprehensive analysis of the global Artificial Heart and Ventricular Assist Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Heart and Ventricular Assist Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Heart and Ventricular Assist Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Heart and Ventricular Assist Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Heart and Ventricular Assist Devices.

The global Artificial Heart and Ventricular Assist Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Artificial Heart and Ventricular Assist Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Artificial Heart and Ventricular Assist Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Artificial Heart and Ventricular Assist Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Artificial Heart and Ventricular Assist Devices players cover SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT and Jarvik Heart Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart and Ventricular Assist Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Artificial Heart
Ventricular Assist Devices

Segmentation by application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artificial Heart and Ventricular Assist Devices market?

What factors are driving Artificial Heart and Ventricular Assist Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artificial Heart and Ventricular Assist Devices market opportunities vary by end market size?

How does Artificial Heart and Ventricular Assist Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.